Refresh

Bliss GVS Pharma Ltd. - Research Center

506197 BLISSGVS Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

605.46 598.34 636.36 465.51 441.95
Expenses

Material consumed

299.47 314.90 343.94 253.30 236.72

Manufacturing expenses

8.81 5.80 7.09 6.99 4.70

Personnel expenses

82.59 72.54 65.06 58.61 44.02

Selling expenses

0.99 0.50 0.14 0.17 0.56

Adminstrative expenses

106.43 114.45 110.92 54.98 55.78

Expenses capitalised

- - - - -

Cost of sales

498.29 508.18 527.16 374.05 341.78

Operating profit

107.17 90.16 109.20 91.46 100.17

Other recurring income

33.50 50.77 32.63 17.68 37.00

Adjusted PBDIT

140.67 140.92 141.83 109.14 137.17

Financial expenses

5.81 10.06 4.32 4.19 6.62

Depreciation

23.52 15.17 13.85 13.76 8.83

Other write offs

- - - - -

Adjusted PBT

111.34 115.69 123.66 91.19 121.71

Tax charges

19.61 30.21 33.74 23.69 29.38

Adjusted PAT

91.73 85.48 89.92 67.50 92.33

Non recurring items

-41.24 -0.67 3.05 0.52 -0.26

Other non cash adjustments

- - - - -

Reported net profit

50.49 84.81 92.97 68.02 92.08

Earnigs before appropriation

896.67 850.15 769.19 681.38 625.77

Equity dividend

5.21 5.19 5.18 5.16 12.41

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

891.46 844.96 764.02 676.22 613.36
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com